ADRNY or CLX: Which Is the Better Value Stock Right Now?

A comparison of two consumer staples stocks reveals that Ahold NV (ADRNY) presents a better value opportunity than Clorox (CLX) for value investors. ADRNY has a stronger Zacks Rank of #2 (Buy) versus CLX's #4 (Sell), along with more attractive valuation metrics including a lower forward P/E ratio (11.26 vs 16.67) and significantly lower P/B ratio (1.8 vs 46.88).